Status:
RECRUITING
A Registered Cohort Study on Duchenne Muscular Dystrophy
Lead Sponsor:
Ning Wang, MD., PhD.
Conditions:
Duchenne Muscular Dystrophy
Eligibility:
All Genders
2+ years
Brief Summary
Dystrophinopathy is a term of X-linked recessive genetic disease, including Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and the X-linked dilated cardiomyopathy. The aim of this study is to...
Eligibility Criteria
Inclusion
- Beyond 2 years old
- Diagnosis with Duchenne Muscular Dystrophy, and female carriers, genotypically confirmed
- Diagnosis should be supported by muscle biopsy, if no genetic confirmation.
Exclusion
- Presence of other clinically significant illness
Key Trial Info
Start Date :
July 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2049
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04012671
Start Date
July 1 2019
End Date
December 31 2049
Last Update
March 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First Affiliated Hospital of Fujian Medical University
Fuzhou, China